Abstract
Purpose
Gallbladder cancer is a highly mortal disease with poor prognosis because of late presentation of disease. Survivin and X-linked inhibitor of apoptosis (XIAP) are one of the two important members of inhibitors of apoptosis. Thus, this study aimed to look at the expression of Survivin and XIAP in gallbladder cancer patients.
Methods
Survivin and XIAP expression were investigated in tissues of gallbladder cancer patients (40 cases) and compared with cholelithiasis as control (40 cases) by using immunohistochemistry. Their expression was correlated with clinicopathological parameters.
Results
Significantly higher (p < 0.05), Survivin protein was expressed in gallbladder cancer (n = 67.5%) than control (n = 35%). But it did not show any significant association with any of the clinicopathological parameter while XIAP was not expressed in the GBC patients (p > 0.05).
Conclusion
Overexpression of Survivin in gallbladder cancer suggests its possible role and association with poor prognosis. But XIAP has not been found to be associated with gallbladder carcinogenesis.
Similar content being viewed by others
References
Hueman M, Vollmer C, Pawlik T. Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol. 2009;16:2101–5. https://doi.org/10.1245/s10434-009-0538-x.
Cobourn N, Cleary S, Tan J, Law CH. Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg. 2008;207:371–82.
Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: past, present and an uncertain future. Surg Oncol. 2012;21(4):e183–91.
Dixit R, Shukla VK, Pandey M. Molecular alterations in gallbladder cancer. World J Pathol. 2012;1:31–4.
Qiu Y, Li X, Yi B, et al. Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer. Oncotarget. 2015;6(22):19148–62.
Henry LR, Lee HO, Lee JS, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13(6):1736–41.
Yang YL, Li XM. The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res. 2000;10(3):169–77.
Ngan CY, Yamamoto H, Seshimo I, et al. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br J Cancer. 2007;96(6):986–92.
Zhu L, Cheng X, Ding Y, et al. Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway. Cancer Lett. 2014;343(1):80–9.
LeBleu VS, Taduri G, O’Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013;19(8):1047–53.
Tu SP, Chi AL, Ai W, et al. p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells. Am J Physiol Gastrointest Liver Physiol. 2009;297(2):G385–96.
Kashkar H. X-linked inhibitor of apoptosis: a chemoresistance factor or a hollow promise. Clin Cancer Res. 2010;16:4496–502.
Srinivasula SM, Ashwell JD. IAPs: what’s in a name? Mol Cell. 2008;30:123–35.
Tamm I, Kornblau SM, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 2000;6:1796–803.
Liu SS, Tsang BK, Cheung AN, et al. Anti-apoptotic proteins, apoptotic and proliferative parameters and their prognostic significance in cervical carcinoma. Eur J Cancer. 2001;37:1104–10.
Krajewska M, Kim H, Kim C, et al. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Clin Cancer Res. 2005;11:5451–61.
Ryan BM, Konecny GE, Kahlert S, et al. Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol. 2006;17:597–604.
Jha K, Shukla M, Pandey M. Survivin expression and targeting in breast cancer. Surg Oncol. 2012a;21:125–31.
Meijer L, Jézéquel A, Roberge M. Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res. 2003;5:447–52.
Zhou S, Ye W, Shao Q, Qi Y, Zhang M, Liang J. Prognostic significance of XIAP and NF-κB expression in esophageal carcinoma with postoperative radiotherapy. World J Surg Oncol. 2013;11:288.
Qin S, Xu C, Li S, et al. Hyperthermia induces apoptosis by targeting Survivin in esophageal cancer. Oncol Rep. 2015;34(5):2656–64.
Wei D, Qi Z, Wei-wen L, Yun-le W. Expression of laminin and survivin in primary gallbladder carcinoma. Chin J Pathophysiol. 2006;22(11):2207–11. (Abstract)
Tanaka M, Chijiiwa K. Carcinoma of the gallbladder: an appraisal of surgical resection. Surgery. 1994;115:751–6.
Kennedy SM, O’Driscoll L, Purcell R, et al. Prognostic importance of survivin in breast cancer. Br J Cancer. 2003;88:1077–83.
Al-Joudi FS, Iskandar ZA, Hasnan J, et al. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast. Singap Med J. 2007;48(7):607.
Jha K, Kumar M, Shukla VK, Pandey M. Survivin expression and correlation with clinico-pathological parameters in breast cancer. World J Pathol. 2012b;1:23–30.
Augello C, Caruso L, Maggioni M, et al. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer. 2009;9:125.
Yie SM, Luo B, Ye NY, Xie K, Ye SR. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA. Clin Exp Metastasis. 2006;23:279–89.
Khan S, Aspe JR, Asumen MG, et al. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer. 2009;100:1073–86.
Nigam J, Chandra A, Kazmi HR, et al. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker? Tumor Biol. 2014;35:9241–6.
Won HS, Lee MA, Chung ES, et al. Comparison of thymidine phosphorylase expression and prognostic factors in gallbladder and bile duct cancer. BMC Cancer. 2010;10:564.
Yim JH, Yoon JH, Kim SA, et al. Expression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorder. J Korean Med Sci. 2011;26:1191–5. https://doi.org/10.3346/jkms.2011.26.9.1191.
Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. IAP regulation of metastasis. Cancer Cell. 2010;17:53–64. https://doi.org/10.1016/j.ccr.2009.11.021.
Chen X, Wang T, Yang D, et al. Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients. Oncol Lett. 2013;5:1278–84.
Rodríguez-Berriguete G, Fraile B, de Bethencourt FR, et al. Role of IAPs in prostate cancer progression: immunohistochemical study in normal and pathological (benign hyperplastic, prostatic intraepithelial neoplasia and cancer) human prostate. BMC Cancer. 2010;10:18. https://doi.org/10.1186/1471-2407-10-18.
Acknowledgements
Departmental research grant for financial support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Dixit, R., Raza, M., Kumar, M. et al. Expression Analysis of Survivin and XIAP in Gallbladder Cancer: a Case-control Study in Indo-Gangetic Plain. J Gastrointest Canc 49, 487–492 (2018). https://doi.org/10.1007/s12029-017-0008-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-017-0008-9